| Cat. No. |
Product Name |
Information |
| PC-26828 |
MRL-494 hydrochloride
BamA inhibitor
|
MRL-494 hydrochloride (MRL494) is an antimicrobial small molecule that inhibits assembly of outer membrane proteins (OMPs) by the β-barrel assembly machine (BAM complex), inhibits the insertion of OMPs into the OM by targeting BamA. |
| PC-26808 |
BRD1554
Mtb Pks13 inhibitor
|
BRD1554 is a selective inhibitor of Mycobacterium tuberculosis polyketide synthase 13 (Pks13). |
| PC-26780 |
Fluorothiazinone
T3SS inhibitor, Anti-virulence
|
Fluorothiazinone is a small molecule antivirulent compound that suppresses the formation of biofilms, inhibits the type III secretion system (T3SS) in Gram-negative bacteria. |
| PC-26720 |
KGDI-109
PgDPP7 inhibitor
|
KGDI-109 is the first substrate-mimetic dipeptide inhibitor of P. gingivalis dipeptidyl peptidase 7 (PgDPP7) with IC50 of 53.8 uM and Ki of 25.1 uM, exerts an inhibitory effect against P. gingivalis growth with MIC of 1.56 uM. |
| PC-26708 |
BDM91531
AcrB efflux pump inhibitor
|
BDM91531 is a potent AcrB efflux pump inhibitor, binds to the TMD of the L state and O state protomers of AcrB, exhibits potent potentiation of pyridomycin activity with EC90 of 0.24 uM. |
| PC-26671 |
Funobactam
β-lactamase inhibitor
|
Funobactam (XNW4107) is a novel β-lactamase inhibitor that possesses broad activity against serine-β-lactamases, displays in vitro activity against Ambler class A, C, and D β-lactamases. |
| PC-26668 |
GM47-1
MmpL3 inhibitor
|
GM47-1 is small molecule inhibitor targeting MmpL3 in Mycobacterium abscessus, has MIC50 of 1.6 uM and trigger a dose-dependent ATP increase with EC50 of 3 uM in Mycobacterium abscessus. |
| PC-26667 |
MSU-156
MmpL3 inhibitor
|
MSU-156 is small molecule inhibitor targeting MmpL3 in Mycobacterium abscessus, has MIC50 of 0.18 uM and trigger a dose-dependent ATP increase with in Mycobacterium abscessus. |
| PC-26666 |
MSU-155
MmpL3 inhibitor
|
MSU-155 is small molecule inhibitor targeting MmpL3 in Mycobacterium abscessus, has MIC50 of 0.21 uM and trigger a dose-dependent ATP increase with in Mycobacterium abscessus. |
| PC-26647 |
PAβN dihydrochloride
Efflux pump inhibitor
|
PAβN dihydrochloride (MC-207,110) is a potent efflux pump inhibitor that potentiates effect of the activity of levofloxacin against both laboratory strains with multiple target mutations and recent clinical isolates of P. aeruginosa. |
| PC-26646 |
MBX-2319
Efflux pump inhibitor
|
MBX-2319 (MBX2319) is a small molecule inhibitor of AcrAB efflux pump of Escherichia coli, enhance the activity of ciprofloxacin, levofloxacin, and piperacillin in Escherichia coli. |
| PC-26645 |
TXA09155
Efflux pump inhibitor
|
TXA09155 is a small molecule efflux pump inhibitor, shows synergistic effect with levofloxacin against multidrug resistant P. aeruginosa clinical isolates, shows ≥8-fold potentiation of levofloxacin, moxifloxacin, doxycycline, minocycline, cefpirome, chloramphenicol, and cotrimoxazole at 6.25 ug/mL. |